Phosphoproteomic Analysis of Human Mesenchymal Stromal Cells during Osteogenic Differentiation
Resource
JOURNAL OF PROTEOME RESEARCH, 11(2), 586-598
Journal
Journal of Proteome Research
Pages
586-598
Date Issued
2012
Date
2012
Author(s)
Lo, Ting
Tsai, Chia-Feng
Shih, Yu-Ru V.
Wang, Yi-Ting
Lu, Sheng-Chieh
Sung, Ting-Yi
Hsu, Wen-Lian
Chen, Yu-Ju
Lee, Oscar K.
Abstract
Human mesenchymal stromal cells (hMSCs) are promising candidates for cell therapy and tissue regeneration. Knowledge of the molecular mechanisms governing hMSC commitment into osteoblasts is critical to the development of therapeutic applications for human bone diseases. Because protein phosphorylation plays a critical role in signaling transduction network, the purpose of this study is to elucidate the phosphoproteomic changes in hMSCs during early osteogenic lineage commitment. hMSCs cultured in osteogenic induction medium for 0, 1, 3, and 7 days were analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS). Surprisingly, we observed a dramatic loss of protein phosphorylation level after 1 day of osteogenic induction. Pathways analysis of these reduced phosphoproteins exhibited a high correlation with cell proliferation and protein synthesis pathways. During osteogenic differentiation, differentially expressed phosphoproteins demonstrated the dynamic alterations in cytoskeleton at the early stages of differentiation. The fidelity of our quantitative phosphoproteomic analyses were further confirmed by Western blot analyses, and the changes from protein expression or its phosphorylation level were distinguished. In addition, several ion channels and transcription factors with differentially expressed phosphorylation sites during osteogenic differentiation were identified and may serve as potentially unexplored transcriptional regulators of the osteogenic phenotype of hMSCs. Taken together, our results have demonstrated the dynamic changes in phosphoproteomic profiles of hMSCs during osteogenic differentiation and unraveled potential candidates mediating the osteogenic commitment of hMSCs. The findings in this study may also shed light on the development of new therapeutic targets for metabolic bone diseases such as osteoporosis and osteomalacia. ? 2011 American Chemical Society.
SDGs
Other Subjects
alkaline phosphatase; osteonectin; phosphoprotein; transcription factor RUNX2; article; cell differentiation; cell proliferation; controlled study; cytoskeleton; human; human cell; liquid chromatography; mesenchymal stroma cell; metabolic bone disease; molecular dynamics; osteoblast; osteogenic differentiation; osteomalacia; osteoporosis; phenotype; phosphoproteomic analysis; priority journal; protein expression; protein phosphorylation; protein synthesis; proteomics; real time polymerase chain reaction; tandem mass spectrometry; Western blotting; Amino Acid Sequence; Analysis of Variance; Blotting, Western; Cell Differentiation; Cell Growth Processes; Cells, Cultured; Chromatography, Liquid; Cytoskeleton; Humans; Mesenchymal Stem Cells; Molecular Sequence Data; Osteogenesis; Phosphoproteins; Phosphorylation; Proteomics; Reproducibility of Results; Tandem Mass Spectrometry
Type
journal article
File(s)![Thumbnail Image]()
Loading...
Name
23.pdf
Size
23.17 KB
Format
Adobe PDF
Checksum
(MD5):7b18b68c7a7a262ec0cc74510151955a